Deoxycorticosterone acetate structure
|
Common Name | Deoxycorticosterone acetate | ||
|---|---|---|---|---|
| CAS Number | 56-47-3 | Molecular Weight | 372.498 | |
| Density | 1.1±0.1 g/cm3 | Boiling Point | 504.1±50.0 °C at 760 mmHg | |
| Molecular Formula | C23H32O4 | Melting Point | 157°C | |
| MSDS | Chinese USA | Flash Point | 218.0±30.2 °C | |
Use of Deoxycorticosterone acetateDeoxycorticosterone acetate is a steroid hormone produced by the adrenal gland that possesses mineralocorticoid activity and acts as a precursor to aldosterone. |
| Name | 21-(acetyloxy)-pregn-4-ene-3,20-dione |
|---|---|
| Synonym | More Synonyms |
| Description | Deoxycorticosterone acetate is a steroid hormone produced by the adrenal gland that possesses mineralocorticoid activity and acts as a precursor to aldosterone. |
|---|---|
| Related Catalog |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 504.1±50.0 °C at 760 mmHg |
| Melting Point | 157°C |
| Molecular Formula | C23H32O4 |
| Molecular Weight | 372.498 |
| Flash Point | 218.0±30.2 °C |
| Exact Mass | 372.230072 |
| PSA | 60.44000 |
| LogP | 4.53 |
| Vapour Pressure | 0.0±1.3 mmHg at 25°C |
| Index of Refraction | 1.542 |
| Storage condition | Refrigerator |
| Water Solubility | H2O: insoluble |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Hazard Codes | Xi |
| Safety Phrases | S22-S24/25 |
| RIDADR | UN 2811 |
| WGK Germany | 3 |
| RTECS | HG0525000 |
| Packaging Group | II |
| Hazard Class | 6.1 |
| Precursor 5 | |
|---|---|
| DownStream 7 | |
|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Toxicol. Mech. Methods 18 , 217-27, (2008) ABSTRACT Drug-induced phospholipidosis (PL) is a condition characterized by the accumulation of phospholipids and drug in lysosomes, and is found in a variety of tissue types. PL is frequently manifes... |
|
|
Antibacterial activity of enrofloxacin and ciprofloxacin derivatives of β-octaarginine.
Chem. Biodivers. 12(2) , 179-93, (2015) β(3) -Octaarginine chains were attached to the functional groups NH and CO2 H of the antibacterial fluoroquinolones ciprofloxacin (→1) and enrofloxacin (→2), respectively, in order to find out whether... |
|
|
Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and lisinopril in DOCA-salt hypertension-induced vascular dementia in rats.
Psychopharmacology 223(3) , 307-17, (2012) Vascular dementia and hypertension are increasing day by day, with a high degree of co-occurrence. Tremendous amount of research work is required so that new pharmacological agents may be identified f... |
| 21-Acetyloxypregn-4-ene-3,20-dione |
| 2-[(8S,9S,10R,13S,14S,17S)-10,13-Dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethylacetat |
| DOXO |
| Descotone |
| Deoxycostone Acetate |
| 2-[(8S,9S,10R,13S,14S,17S)-10,13-Dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl acetate |
| Pregn-4-ene-3,20-dione, 21- (acetyloxy)- |
| 3,20-Dioxopregn-4-en-21-ylacetat |
| Desoxycorticosterone acetate (USP) |
| Doca |
| Syncort |
| [2-[(8S,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate |
| Acétate de 2-[(8S,9S,10R,13S,14S,17S)-10,13-diméthyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tétradécahydro-1H-cyclopenta[a]phénanthrén-17-yl]-2-oxoéthyle |
| 3,20-Dioxopregn-4-en-21-yl acetate |
| MFCD00003660 |
| EINECS 200-275-9 |
| Pregn-4-ene-3,20-dione, 21-(acetyloxy)- |
| Deoxycorticosterone acetate |